Patient Education

In grim milestone, United States logs world’s highest coronavirus death toll

Apr 11, 2020

By Maria Caspani and Jonathan Allen NEW YORK (Reuters) – The United States surpassed Italy...

What Does Recovery From COVID-19 Look Like? It Depends. A Pulmonologist Explains.

Apr 9, 2020

Reports of recovery from serious illness caused by the coronavirus have been trickling in from around the world.Physicians are swapping anecdotes on social media: a 38-year-old man who went home after three weeks at the...

Special Considerations: A Patient’s Perspective on Covid-19— Deb’s Journey

Apr 9, 2020

In this exclusive video, medical writer Deb Liao, PharmD, shares her experience as a Covid-19...

Explainer: Do men fare worse with COVID-19?

Apr 8, 2020

By Kate Kelland LONDON (Reuters) – Death and infection tolls from the COVID-19 pandemic...

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.

Apr 7, 2020

In December 2019, the Coronavirus disease-2019 (COVID-19) virus has emerged in Wuhan, China. In...

Italy’s Diasorin aims to launch COVID-19 antibody test by end-April

Apr 7, 2020

MILAN (Reuters) – Italy’s medical diagnostic group Diasorin said on Tuesday it aims to...

School closures will have little impact on COVID-19 control, review finds

Apr 6, 2020

By Kate Kelland LONDON (Reuters) – School closures do not tend to help contain the spread of...

GSK to partner with Vir for potential COVID-19 treatments, invest $250 million

Apr 6, 2020

By Trisha Roy and Manas Mishra (Reuters) – British drugmaker GlaxoSmithKline will invest...

Experts urge smokers and tobacco firms to quit for COVID-19

Apr 6, 2020

LONDON (Reuters) – Health experts on Monday urged smokers to quit and cigarette companies to...

Majority of Physicians Report Serious Concerns About COVID-19

Apr 6, 2020

National survey shows concerns regarding adequacy of supplies and COVID-19 testing

UK’s Izana Bioscience tests rheumatoid arthritis drug in COVID-19 patients

Apr 5, 2020

LONDON (Reuters) – UK-based biopharma company Izana Bioscience said it was testing its antibody therapy namilumab for the treatment of patients with rapidly worsening COVID-19 at the Humanitas Research Hospitals in Bergamo...